Carroll Financial Associates’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Carroll Financial Associates’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$21K	Hold	191	–	–	﹤0.01%	968
2021 Q3	$24K	Buy	191 +50	+35%	+$6.44K	﹤0.01%	949
2021 Q2	$19K	Sell	141 -1,908	-93%	-$251K	﹤0.01%	1113
2021 Q1	$278K	Buy	2,049 +41	+2%	+$6.14K	0.02%	337
2020 Q4	$282K	Buy	2,008 +858	+75%	+$110K	0.02%	310
2020 Q3	$128K	Sell	1,150 -2,527	-69%	-$283K	0.01%	429
2020 Q2	$411K	Buy	3,677 +3,536	+2,508%	+$348K	0.03%	246
2020 Q1	$10K	Hold	141	–	–	﹤0.01%	953
2019 Q4	$13K	Hold	141	–	–	﹤0.01%	989
2019 Q3	$10K	Hold	141	–	–	﹤0.01%	1017
2019 Q2	$12K	Hold	141	–	–	﹤0.01%	964
2019 Q1	$12K	Sell	141 -100	-41%	-$8.51K	﹤0.01%	899
2018 Q4	$19K	Hold	241	–	–	﹤0.01%	688
2018 Q3	$23K	Hold	241	–	–	﹤0.01%	670
2018 Q2	$22K	Hold	241	–	–	﹤0.01%	655
2018 Q1	$21K	Buy	241 +100	+71%	+$9.13K	﹤0.01%	664
2017 Q4	$11K	Hold	141	–	–	﹤0.01%	814
2017 Q3	$12K	Hold	141	–	–	﹤0.01%	781
2017 Q2	$10K	Buy	+141	New	+$10K	﹤0.01%	839

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Carroll Financial Associates's XBI Position: Q4 2021 in Review

Carroll Financial Associates held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q4 2021 at 191 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #968.

Carroll Financial Associates first reported a position in XBI in Q2 2017 and has held it in 19 quarters since. The position peaked at $411K in Q2 2020. 702 funds tracked by Wall St. Rank hold XBI as of Q4 2021.

Carroll Financial Associates held 191 shares of State Street SPDR S&P Biotech ETF worth $21K as of Q4 2021.
Carroll Financial Associates left its State Street SPDR S&P Biotech ETF share count unchanged in Q4 2021.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #968 holding.
Carroll Financial Associates first reported a position in State Street SPDR S&P Biotech ETF in Q2 2017 and has held it in 19 quarters since.
Carroll Financial Associates's State Street SPDR S&P Biotech ETF position peaked at $411K in Q2 2020.
702 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.